NEW YORK (GenomeWeb News) — Compugen yesterday said it posted revenues for the third quarter of 2007 compared with none from the year-ago period, while R&D spending slid 8 percent and net loss grew by 8 percent.
 
The company reported $90,000 in revenue for the three months ended Sept. 30 compared with no revenue year over year.           
 
Compugen CEO Alex Kotzer said the revenue came from a milestone payment from an existing immunoassay diagnostic agreement.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.